INTERNATIONAL STEM CELL CORPORATION — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $2M | ↓-11.9% | — | — | — |
| 2025-09-30 | $2M | ↑+8.7% | $57K | ↑+145.6% | 4.0% |
| 2025-06-30 | $2M | ↑+5.0% | $129K | ↑+8.4% | 6.8% |
| 2025-03-31 | $2M | ↑+0.0% | $-256K | ↓-19.6% | -10.1% |
| 2024-12-31 | $2M | ↑+29.5% | $11K | — | 0.9% |
| 2024-09-30 | $2M | ↑+10.4% | $-125K | ↑+4.6% | -4.1% |
| 2024-06-30 | $2M | ↑+26.6% | $119K | ↓-75.8% | 6.4% |
| 2024-03-31 | $2M | ↑+2.1% | $-214K | ↓-529.4% | -8.4% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Go deeper
ISCO Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyISCO Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics